Swine vesicular disease surveillance and eradication activities in Italy S. Bellini

Rev. sci. tech. Off. int. Epiz., 2007, 26 (3), 585-593
Swine vesicular disease surveillance
and eradication activities in Italy
S. Bellini (1), U. Santucci (2), G. Zanardi (1), E. Brocchi (1) & R. Marabelli (2)
(1) Centro Nazionale di Referenza per le Malattie Vescicolari, Istituto Zooprofilattico Sperimentale della
Lombardia e dell’Emilia Romagna. Via Bianchi 9, 25124 Brescia. Email: [email protected]
(2) Dipartimento della Prevenzione e della Comunicazione, Direzione Generale della Sanità Veterinaria
e degli Alimenti
Submitted for publication: 3 May 2006
Accepted for publication: 18 May 2007
Summary
Swine vesicular disease (SVD) was first observed in Italy in 1966, and was
initially diagnosed as foot and mouth disease (FMD). The causative agent of SVD
was classified as an Enterovirus within the family Picornaviridae. It was included
in the list of diseases notifiable to the World Organisation for Animal Health (OIE)
because of the similarity of its lesions to those produced by FMD; however SVD
is often mild in nature and may infect pigs subclinically.
During the last decade SVD has been persistently reported in Italy, and
surveillance and eradication activities are in place. The central and northern
parts of Italy have been designated SVD free since 1997, while the southern
regions have not achieved disease-free status. However, occasional outbreaks
of SVD have occurred in central and northern Italy and have been eradicated
using rigorous control measures.
Most recent SVD outbreaks in Italy have been subclinical; SVD can rarely be
diagnosed now on the basis of clinical signs and it is necessary to use laboratory
diagnosis.
This paper examines the epidemiology of SVD in Italy, and considers the
measures adopted in Europe for SVD control on the basis of current knowledge
of the disease.
Keywords
Eradication – Italy – Surveillance – Swine vesicular disease.
Introduction
Swine vesicular disease (SVD) was first observed in Italy in
1966, when it was identified clinically as foot and mouth
disease (FMD) (16). Despite the production of similar
clinical signs, the biological, physical and chemical
properties of the virus showed that it differed from FMD,
vesicular stomatitis and vesicular exanthema viruses.
Swine vesicular disease virus (SVDV) was classified as an
Enterovirus within the family Picornaviridae. Phylogenetic
studies suggest that it evolved as a genetic sub-lineage of
the human pathogen coxsackievirus B5 between 1945 and
1965 (20). Although all current SVDV isolates are of a
single serotype, four antigenic variants, distinguishable by
the use of monoclonal antibodies, have been reported since
its first appearance (8). The most recent group consists of
viruses isolated in European Union (EU) countries since
1992. This variant, which has maintained a stable antigenic
profile, has been circulating in Italy for more than 10 years,
and has sporadically been detected in other EU countries
and in Taipei China (5).
Swine vesicular disease virus is extremely resistant in the
environment and to normal disinfectants; the virus is noted
for its persistence over a pH range from 2.5 to 12. The
extraordinary stability in the environment of SVDV is a
feature of major importance in the epidemiology and
control of the disease (15).
586
Swine vesicular disease virus causes a vesicular disease in
pigs, with clinical signs that resemble those of foot and
mouth disease, but it does not affect ruminants. Direct
contact of susceptible animals with infected pigs or
contaminated materials, premises or transport vehicles is
usually necessary for disease transmission. The infection
can also be transmitted via the feeding of meat from pigs
slaughtered during the viraemic period or offal from
infected pigs.
Unlike FMD, swine vesicular disease has a limited
tendency to diffuse, even within infected premises. Spread
from one pen to another may not occur in the absence of
movement of infected pigs or contaminated material. This
is why SVD is regarded as a ‘pen disease’ rather than a ‘farm
disease’ (15).
The viraemic period of SVD lasts for two to three days.
After virus has been cleared from the blood and most
internal organs, it can still replicate in the gastrointestinal
tract and be shed in the faeces for a period of days
to weeks.
Rev. sci. tech. Off. int. Epiz., 26 (3)
that the disease is included in the OIE list of notifiable
diseases (10).
Similar to the legislation on FMD control, in the case of
confirmation of SVD, Directive 92/119/EEC provides for a
rigorous stamping-out policy, together with the
establishment of protection and surveillance zones in
which movements of pigs are restricted or banned, and
cleansing and disinfection of infected premises
and vehicles.
Diagnostic procedures for swine vesicular disease are laid
down at Community level in Commission Decision
2000/428/EC. This establishes diagnostic procedures,
sampling methods and criteria for the evaluation of the
results of laboratory tests for the confirmation and
differential diagnosis of swine vesicular disease (11). The
Decision does not lay down requirements for routine
surveillance, which have been established for Italy by
Commission Decision 2005/779/EC ‘concerning animal
health protection measures against swine vesicular disease
in Italy’ (13).
The disease is characterised by the appearance of vesicular
lesions on the limbs, snout, lips and tongue of pigs; the
severe form is usually only seen when animals are housed
on a concrete floor in humid conditions (9). However, SVD
is often mild in nature and may infect pig herds
subclinically. Stress caused by mixing and transporting
animals may play an important role in increasing virus
shedding, the severity of clinical signs and the likelihood of
further spread of disease.
In 1973, Italy placed SVD on its list of notifiable diseases.
A surveillance plan has been implemented since 1995, the
aim of which is to achieve eradication by means of an SVD
health certification scheme in each Italian region. The plan
is updated annually according to the epidemiological
situation and has been approved by the EU Commission.
The main activities of the plan are:
Although the disease is frequently mild in nature it was
included in the list of diseases notifiable to the OIE because
of the similarity of its lesions to those produced by FMD.
If pigs show suspicious clinical signs, rapid differentiation
between FMD and SVD is necessary. Very sensitive and
specific tests are available for SVD diagnosis and for its
differentiation from FMD.
– a virological check of faecal samples collected from
dealers’ premises (virus monitoring on dealers’ premises
was introduced in 1998)
– a random serological check of all breeding farms
– random serological monitoring of imported pigs
(introduced in 2001).
In the majority of recent outbreaks in Italy, the course has
been subclinical; in such cases, SVD can rarely be
diagnosed on the basis of clinical signs and it is necessary
to resort to laboratory investigation (4).
Extraordinary control measures have been adopted at the
regional level in cases where there is a serious risk of
disease spread (for example Campania, Calabria) or when
the disease has occurred in an area with a high density
of pigs (e.g. Lombardy in 1999 and 2002) (18, 19).
During the last decade, SVD has been persistently reported
in Italy and for this reason surveillance and eradication
activities are currently in place.
Declaration of an SVD outbreak follows the rule laid down
in Directive 92/119 (10), which establishes that SVD is
confirmed:
a) on holdings in which SVDV is detected either in pigs or
in the environment;
Swine vesicular disease
control measures
b) when the holding contains pigs that are seropositive for
SVD, provided those pigs or others on the holding show
lesions characteristic of SVD;
Swine vesicular disease control measures are currently
established in the EU by Council Directive 92/119/EEC,
Annex II. These measures take into consideration the fact
c) when the holding contains pigs that show clinical signs
of disease or are seropositive, provided there is a direct
epidemiological connection with a confirmed outbreak;
587
Rev. sci. tech. Off. int. Epiz., 26 (3)
d) on any holding where seropositive pigs are detected. In
this case, before confirming the presence of the disease,
further investigations are undertaken, in particular
resampling and retesting with an interval of at least 28 days
between successive samples. If subsequent investigations
show no evidence of the disease, but the pigs are still
seropositive, the competent authority ensures that the pigs
tested are slaughtered.
As soon as the presence of the disease is suspected the
competent authority carries out an epidemiological
investigation to determine the possible origin of the disease
on the holding. The origin of the disease must be traced
and the spread of infection stopped.
In order to collect and analyse the data gathered during the
surveillance activities for SVD in Italy, a web-based
information system for the management of the national
surveillance plan has been implemented (3).
Laboratory diagnosis
and virus characterisation
Due to the characteristic subclinical course of the disease,
clinical inspection is frequently inconclusive; for a
surveillance plan aimed at SVD eradication it is therefore
necessary to resort to laboratory diagnosis.
In Italy laboratory diagnosis is carried out according to the
rules laid down in EC Decision 2000/428 (11) and in
the OIE Manual of Diagnostic Tests and Vaccines for
Terrestrial Animals (17).
Antibody detection
The OIE reference test, which is a competitive enzymelinked immunosorbent assay (ELISA) based on the
monoclonal antibody 5B7, is used as a screening test
(7, 17). Serological screening is carried out at regional level
using kits supplied by the National Reference Laboratory
(NRL) in Brescia. The performance of the screening test in
the regional laboratories is monitored yearly through ring
tests organised by the NRL. Confirmatory testing of
doubtful and positive samples is performed at the NRL
using the prescribed virus neutralisation test. All positive
sera are also submitted to an isotype-specific ELISA to
identify the class of anti-SVDV immunoglobulins, in
particular IgM and IgG. The presence of IgM, alone or
together with IgG, is evidence of recent infection and
indicative of virus shedding, while detection of IgG alone
suggests an older infection (7).
Virus detection
Virological tests are carried out at the NRL. For virological
testing of faecal samples (for surveillance and in suspected
outbreaks) the recommended virus isolation (VI) test was
used until 2002. Since then, virus isolation has been
replaced by a reverse transcriptase polymerase chain
reaction (RT-PCR). The RT-PCR is based on preliminary
immunocapture of SVDV by a monoclonal antibody coated
on to an ELISA plate; this strategy prevents false-negatives
that may occur due to the presence of inhibitors of the
reaction in faecal samples.
The immune-PCR was extensively validated on a large
number of field samples, and showed advantages in terms
of sensitivity, rapidity (1–2 days vs 1 week) and simplicity
compared with the ‘confirmatory’ VI test (14). The VI test
is performed on IBRS-2 or equivalent cell lines and often
requires two to four subcultures. The cell lines used are
susceptible to SVD virus as well as to other enteroviruses
potentially present in porcine faeces. Samples containing
other viruses may give a false-negative result for SVDV
when growth of the other enteroviruses exceeds or affects
the growth of SVDV. In our experience, the prevalence of
enteroviruses other than SVDV in faeces samples submitted
for the VI assay corresponds to 20% to 25% of the samples
examined. Moreover, due to inadequate preservation and
transportation of samples, the SVD virus present in faecal
samples may no longer be viable.
Due to these limitations, a proportion of faeces samples
that are positive by immune-PCR score negative when
examined by the reference VI assay. The specificity and
higher diagnostic sensitivity of the immune-PCR are
supported by evidence that, whenever conditions have
enabled us to perform follow-up testing, all samples
positive on immune-PCR, even when the VI test failed to
confirm the positive result, originated from seropositive
herds or farms epidemiologically connected with
previously confirmed outbreaks. In these cases, the
positive immune-PCR results were used to declare an
outbreak, because the criteria established in EU
Commission Decision 2000/428/EC were fulfilled (11).
Follow-up testing is seldom feasible on dealers’ premises,
due to the conditions of management and husbandry.
Taking into account the role such premises play in the
spread of disease, restrictive criteria are applied to farms of
this type. Any positive immune-PCR result from a
dealership is considered to represent an outbreak.
Characterisation of swine vesicular disease
virus isolates
The antigenic profile of SVDV isolates collected from
outbreaks was studied at the Italian Reference Laboratory
using panels of monoclonal antibodies that identify six
588
The pattern of reactivity with monoclonal antibodies
provided evidence that all the isolates belonged to the
fourth and most recent antigenic group, which was first
detected in the EU in 1992 (8) and is still circulating (6).
Antigenic drift was observed in one antigenic site, which
was subject to frequent variability; other minor antigenic
mutations were extremely sporadic and did not become
stabilised in the field, leading to the conclusion that the
antigenic profile of SVDV isolates collected over
approximately 15 years (1992 to 2005) has been stable.
The results of nucleotide sequencing confirmed that the
isolates are clustered in a unique genomic lineage, which is
known to be correlated to the fourth antigenic group (8),
although progressive genomic divergence is apparent from
the older (isolated in 1992 and 1993) to the more recent
isolates. An exception to this tendency concerns two
geographically related isolates from 2004, which clustered
in a distinguishable genomic sub-lineage together with
viruses isolated in Portugal at the end of 2003 and the
beginning of 2004. This cluster appears to be most closely
related to older isolates, and in particular to one strain
isolated in Portugal in 1995 (N. Knowles and D. Paton,
unpublished data). One explanation could be that SVDV
has persisted unchanged in parts of Europe since the
1990s and has later resurfaced in Portugal, from where it
may have spread to Italy. Alternatively, this cluster could
represent a reintroduction from outside the European
Union, where subclinical infection may be missed in the
absence of active surveillance.
Surveillance and eradication
activities in Italy: results
The results of the main activities of the surveillance plan in
Italy are reported in Figures 1 and 2; the results
correspond to a 10-year period for breeding farms and a
period of 8 years for dealers’ premises. During the 10-year
period the criteria for control of the disease on farms have
changed slightly.
The central and northern parts of Italy are designated SVD
free and have maintained this health status since 1997,
while Campania, Calabria and Sicilia have never attained
SVD-free status (Figure 3).
In recent years SVD outbreaks have been persistently
identified in the regions that do not have disease-free
status; however from time to time SVD outbreaks have
occurred in other regions, both in central and in northern
Seroprevalence
2
1.57
1.5
1
1.21
0.5
0
1995 1996
1.16
1.08
0.94
0.86
1
0.87
0.99
0.98
1997
1998
1999
2000
Year
0.36
2001 2002
2003
2004
2005
Fig. 1
Serosurveillance on breeding farms (1995 to 2005)
Percentage of tested farms
giving positive results
characterised antigenic sites (6), while genomic analyses
were conducted at the EU Reference Laboratory by
comparison of VP1-coding sequences.
Rev. sci. tech. Off. int. Epiz., 26 (3)
9
8
7
6
5
4
3
2
1
0
8.22
7.48
5.63
3.81
2.93
1.99
1998
1999
2000
1.9
1.38
2001
2002
2003
2004
2005
Year
Fig. 2
Virological surveillance on dealers’ premises (1998 to 2005)
Italy (in 2002 and 2004). These outbreaks have always
been eradicated following the adoption of rigorous control
measures, and on some occasions extraordinary
surveillance plans have been implemented to verify SVD
eradication (Lombardy, 1999 and 2002) (18, 19).
In 2004 Abruzzo was regionalised and lost its SVD-free
status because 65 outbreaks were identified and the origin
of the infection remained unknown. At the end of 2006 a
new SVD epidemic occurred in the northern region of
Italy; the relevant data are not included in this report
because eradication activities are still ongoing.
In the 5 years between 2001 and 2005, a total of
352 outbreaks were detected in Italy:
– 32 (9.1%) on breeding farms; of these, 19 (59.3%) were
primary outbreaks, while 13 (40.3%) were secondary
– 71 (20.2%) on dealers’ premises; of these, 59 (83.1%)
were primary outbreaks and 12 (16.9%) were secondary
– 249 (70.7%) on fattening farms; of these, 19 (7.6%)
were primary and 230 (92.3%) were secondary outbreaks.
Fattening farms were most commonly involved in these
outbreaks; SVD was usually detected by tracing animals
back to infected dealers’ premises. In fact, the outbreaks on
fattening farms were very often secondary outbreaks.
These farms, given the specific role they play in
the production cycle, have an extremely limited part in the
spread of the disease. Moreover, 84% of the cases
concerned small-sized holdings with fewer than
10 animals, which were often reared for home
consumption and represented a dead end for
disease spread.
589
Rev. sci. tech. Off. int. Epiz., 26 (3)
Trentino alto Adige
Friuli Venezia Giulia
Aosta valley
Lombardy
Veneto
Piedmont
Emilia Romagna
Liguria
Tuscany
Marches
Umbria
Abruzzo
Lazio
Molise
Puglia
Campania
Basilicata
Sardinia
Calabria
Sicily
SVD-infected region
SVD-free region
0
100
200
km
Fig. 3
Regions of Italy infected with, and designated free from, swine vesicular disease (SVD)
An important role in the spread of SVD was played by
dealers’ premises, which gave rise to 261 (74.1%) of the
outbreaks detected in the 5-year period. The origin
of the infection in these holdings very often remained
unknown (83.1% of primary outbreaks), this could be due
to weaknesses in the systems of pig registration and
recording of animal movements. Furthermore, when
dealers’ premises represented secondary outbreaks, the
origin was traced to another dealer’s premises in 100% of
cases. This confirms the presence of a network among
dealers that enhances disease spread.
movements of pigs, transportation vehicles and
contaminated material. Results of the epidemiological
investigations confirmed that, unlike FMD, SVD has a
limited tendency to spread even between pens of the same
farm. Hence, the incursion of SVD on to a farm or in to
a ‘new territory’ can be avoided by adopting routine
biosecurity measures.
According to the epidemiological investigations carried out
during the outbreaks, SVD diffusion was mainly related to
Since 2000 a change in the clinical trend of SVD was
highlighted (Figure 4): no clinically affected animals were
Despite the possibility of persistence of SVDV in meat
originating from infected pigs, swill feeding has not been
found to be an important cause of disease spread in Italy.
Rev. sci. tech. Off. int. Epiz., 26 (3)
125
18
5
25
16
31
15
5
13
12
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
No. of outbreaks
50.0
45.0
40.0
35.0
30.0
25.0
20.0
15.0
10.0
5.0
0.0
morbidity
Fig. 4
Swine vesicular disease outbreaks in Italy (1995 to 2005),
and morbidity rate
found on 342 out of 357 holdings (95.8%) on which SVD
outbreaks were confirmed in the period 2000 to 2005, and
mortality in these outbreaks was almost nil (24/21, 048;
0.1%). The lack of clinical signs made clinical diagnosis
impossible. The continued presence of SVD in Italy was
detected by means of the surveillance included in the
framework of the eradication programme put in place
in 1995, which includes serological and virological
monitoring of pig holdings, collection centres and
dealers’ premises.
Discussion
The results of the epidemiological investigations
conducted during the 2000-2005 outbreaks in Italy
confirmed that SVD spread is related to the movement of
animals (growers and sows), personnel and contaminated
vehicles from the infected farms. The virus is highly
resistant in the environment, and hygiene measures on
farms and transportation vehicles are not always correctly
applied. The different types of pig farms involved in the
production cycle, and hence the management and
frequency of animal and vehicle movements, played a
varying role in disease spread. Dealers’ premises were
found to play an important role in the spread of the
disease, and on these farms the origin of the infection often
remained unknown. Weaknesses in the swine registry and
in recording of animal movements may compromise
eradication activities.
Due to the frequently subclinical or undisclosed course of
SVDV infection, surveillance and eradication activities are
difficult to carry out; in fact, the early detection phase can
be missed and often by the time the disease is identified it
has already spread. Given the subclinical course of the
infection, at present SVD in Italy does not represent a
‘health problem’ but a commercial issue. People operating
in the sector do not understand the need for commercial
restrictions following the confirmation of an outbreak
because they do not perceive the economic importance of
the disease, and, consequently, they do not participate in
the control measures.
The Italian regions have never attained SVD-free status
simultaneously. This is partly due to the different farm
management situations that exist within Italian territory.
Intensive breeding predominates in the northern and
central parts of the country; therefore there are strong
and understandable reasons why breeders here would like
to maintain an SVD-free zone. The free zone enables them
to export live animals and by-products abroad. The same
economic and commercial motivations are not shared by
southern breeders; in this region there are mainly small
family holdings and farmers are therefore less interested in
exporting their products.
In an SVD outbreak all the animals, their products and
equipment have to be destroyed, and the owner is
compensated for 100% of the market value (1, 2).
The detection and rate of reporting of certain contagious
benign diseases, such as SVD, in densely populated areas
should be considered in the light of market price trends at
the moment of detection. It should be remembered that
when the first outbreak of the 1998 to 1999 epidemic in
the Lombardy region was initially detected, it coincided
with the lowest point of a market downtrend and the
disease notification came from the breeder himself (18)
(Fig. 5).
According to Directive 92/119/EC, which was first
enforced in 1992 and has not been subsequently updated,
suspicion of SVD and imposition of the related control
measures are based on clinical evidence. Given what we
now know about this disease it is clear that this is no longer
adequate: due to the subclinical course, clinical
examination is ineffective and the infection may be missed.
Price in Italian lire
171
2,700
2,400
2,100
1,800
1,500
Jan
Feb
Mar
Apr
May Jun Jul
Month
Aug
Sep
Oct
Nov Dec
Oct
Nov Dec
heavy pig 176-180 kg (1998)
Price in Italian lire
180
160
140
120
100
80
60
40
20
0
Morbidity (percentage)
No. of outbreaks
590
6,000
4,000
2,000
0
Jan
Feb
Mar
Apr
May Jun Jul
Month
Aug
Sep
weaner pig 30 kg (1998)
Fig. 5
Trends in swine market prices for weaners and heavy pigs (1998)
1000 lire = approximately 0.50 euros
591
Rev. sci. tech. Off. int. Epiz., 26 (3)
Currently, SVDV infection can only be confirmed
or excluded by means of laboratory investigation.
Therefore sero-surveillance is essential to detect subclinical
or undisclosed clinical infection and to prove the absence
of the virus.
Apart from Italy, the only other countries in the EU to have
implemented extensive surveillance programmes for SVD
are the Netherlands and Spain. A certain level of serosurveillance is in place in several Member States, while in
others there is very little, or, in some cases, none at all.
These States still rely on SVD detection by farmers or
veterinarians on the basis of clinical signs (12).
surveillance based on laboratory testing should be
extended to the other Member States and surveillance
criteria and guidelines should be established by the OIE.
This would be necessary to ensure disease freedom and the
immediate application of appropriate control measures to
prevent spread should disease be detected.
The reason why SVD in Italy often has a subclinical course
has not yet been explained; it could be related to the
improved management and husbandry conditions on pig
farms or the consequence of a decrease in virulence of the
current Italian strain of the virus. If the latter is true we
cannot exclude the possibility that the virus may re-acquire
its original level of virulence.
Hence, if the disease continues to be considered a serious
threat, the current legislation should be modified to take
into account the recent knowledge of SVD. Compulsory
Activités de surveillance et d’éradication de la maladie
vésiculeuse du porc en Italie
S. Bellini, U. Santucci, G. Zanardi, E. Brocchi & R. Marabelli
Résumé
La maladie vésiculeuse du porc, confondue initialement avec la fièvre aphteuse,
a été signalée pour la première fois en Italie en 1966. L’agent responsable de
la maladie vésiculeuse du porc est un Enterovirus appartenant à la famille des
Picornaviridae. La maladie figure dans la liste des maladies à déclaration
obligatoire de l’Organisation mondiale de la santé animale (OIE) en raison de la
similitude des lésions qu’elle induit avec celles attribuables à la fièvre aphteuse ;
néanmoins, la maladie vésiculeuse du porc se présente souvent sous forme
infraclinique et mineure.
La maladie vésiculeuse du porc est présente en Italie depuis une dizaine
d’années et fait l’objet de mesures de surveillance et d’éradication. Les régions
du centre et du nord de l’Italie sont déclarées indemnes de maladie vésiculeuse
du porc depuis 1997, tandis que les régions du sud n’ont pas encore réussi à
éradiquer la maladie. Quelques foyers épisodiques de maladie vésiculeuse du
porc ont néanmoins été signalés dans le centre et le nord de l’Italie, éradiqués
par des mesures de contrôle strictes.
Les derniers foyers de maladie vésiculeuse du porc survenus en Italie étaient
des infections infracliniques ; il est rare que la maladie vésiculeuse du porc
puisse être diagnostiquée sur la base des signes cliniques de sorte que le
diagnostic doit être fait au laboratoire.
Les auteurs exposent l’épidémiologie de la maladie vésiculeuse du porc en Italie
et examinent les mesures de lutte adoptées en Europe à la lumière des
connaissances actuelles sur la maladie.
Mots-clés
Éradication – Italie – Maladie vésiculeuse du porc – Surveillance.
592
Rev. sci. tech. Off. int. Epiz., 26 (3)
Vigilancia y actividades de erradicación de la enfermedad
vesicular porcina en Italia
S. Bellini, U. Santucci, G. Zanardi, E. Brocchi & R. Marabelli
Resumen
En 1966 fue observada por primera vez en Italia la enfermedad vesicular porcina
(EVP), diagnosticada en un principio como fiebre aftosa. El agente causal de la
EVP fue clasificado como un Enterovirus de la familia Picornaviridae. La EVP fue
incluida en la lista de enfermedades de notificación obligatoria a la Organización
Mundial de Sanidad Animal (OIE) por la similitud de sus lesiones con las
que induce la fiebre aftosa. La EVP, sin embargo, suele revestir carácter leve
e incluso puede ocasionar infecciones asintomáticas.
En el ultimo decenio se ha comunicado una y otra vez la presencia de EVP en
Italia, por lo que ahora mismo hay medidas de vigilancia y erradicación
en marcha. Las zonas central y septentrional del país fueron declaradas “libres
de la enfermedad” en 1997, estatuto al que aún no han accedido las regiones
meridionales. Sin embargo, en el centro y el norte de Italia se han seguido
produciendo brotes ocasionales, que han sido erradicados gracias a estrictas
medidas de control.
Los brotes más recientes de EVP en Italia han sido de carácter subclínico. Hoy
en día pocas veces es posible diagnosticar la enfermedad atendiendo
a la sintomatología, por lo que es preciso emplear el diagnóstico de laboratorio.
Los autores examinan la epidemiología de la EVP en Italia y las medidas
adoptadas en Europa para controlarla, basadas en lo que actualmente se sabe
de la enfermedad.
Palabras clave
Enfermedad vesicular porcina – Erradicación – Italia – Vigilancia.
References
1. Anon. (1988). – Legge 2 giugno 1988, n. 218. Misure per la
lotta contro l’afta epizootica e altre malattie epizootiche degli
animali. Gazz. Uff. Repubb. Ital. Ser. Gen., 144, 3-5.
2. Anon. (1989). – Regolamento per la determinazione dei
criteri per il calcolo del valore di mercato degli animali
abbattuti ai sensi della Legge 2 giugno 1988, n. 218, recante
misure per la lotta contro l’afta epizootica e altre malattie
epizootiche degli animali. Gazz. Uff. Repubb. Ital. Ser. Gen.,
198, 10-17.
3. Bellini S., Ferrarini N. & Santucci U. (2006). –
Implementation of an integrated information system for the
management of surveillance activities for swine vesicular
disease in Italy. In 1st OIE International Conference on ‘Use
of Geographic Information Systems (GIS) in Veterinary
Activities’, 8-11 October; Silvi Marina, Teramo, Italy.
4. Bellini S., Zanardi G. & Brocchi E. (2003). – Swine vesicular
disease in Italy: results of the surveillance and eradication
activities and alternative choice of control strategies for
disease management. In 10th Symposium of the International
Society for Veterinary Epidemiology and Economics (ISVEE),
17-21 November, Viña del Mar, Chile.
5. Borrego B., Bugnetti M., Berlinzani A., De Simone F. &
Brocchi E. (2000). – Stability of the antigenic profile of swine
vesicular disease virus isolates collected during 8 years
(1992–1999). In Proceedings of the 5th International
Congress of the European Society for Veterinary Virology:
Veterinary virology in the new millennium, Brescia,
27-30 August (E. Brocchi & A. Lavazza, eds). Istituto
Zooprofilattico Sperimentale della Lombardia e dell’Emilia
Romagna e Fondazione Iniziative Zooprofilattiche
e Zootecniche, Brescia, 169-170.
Rev. sci. tech. Off. int. Epiz., 26 (3)
6. Borrego B., Carra E., Garcia-Ranea J.A. & Brocchi E. (2002).
– Characterization of neutralization sites on the circulating
variant of swine vesicular disease virus: a new site is shared
by swine vesicular disease and the related coxsackie B5 virus.
J. gen. Virol., 83, 35-44.
7. Brocchi E., Berlinzani A., Gamba D. & De Simone F. (1995).
– Development of two novel monoclonal antibody-based
ELISAs for the detection of antibodies and the identification
of swine isotypes against swine vesicular disease virus. J. virol.
Meth., 52, 155-167.
8. Brocchi E., Zhang G., Knowles N.J., Wilsden G.,
McCauley J.W., Marquardt O., Ohlinger V.F. & De Simone F.
(1997). – Molecular epidemiology of recent outbreaks of
swine vesicular disease: two genetically and antigenically
distinct variants in Europe, 1987-1994. Epidemiol. Infect.,
118, 51-61.
9. Dekker A. (2000). – Pathogenesis, diagnosis and
epizootiology of swine vesicular disease. PhD thesis, Utrecht
University.
10. European Union (1992). – Council Directive 92/119/EEC of
17 December 1992 introducing general Community
measures for the control of certain animal diseases and
specific measures relating to swine vesicular disease. Off. J.
Eur. Communities, L62, 69-86.
11. European Union (2000). – Commission Decision
2000/428/EC of 4 July 2000 establishing diagnostic
procedures, sampling methods and criteria for the evaluation
of the results of laboratory tests for the confirmation and
differential diagnosis of swine vesicular disease. Off. J. Eur.
Communities, L167, 22-32.
12. European Union (2002). – Swine vesicular disease policy:
which options for the future? – EU Commission Working
Document; SANCO/10708/2002 rev 1.
13. European Union (2005). – Commission Decision
2005/779/EC of 8 November 2005 concerning animal health
protection measures against swine vesicular disease in Italy.
Off. J. Eur. Communities, L293, 28-32.
593
14. Fallacara F., Pacciarini M., Bugnetti M., Berlinzani A. &
Brocchi E. (2000). – Detection of swine vesicular disease
virus in faeces samples by immune-PCR assay. In Proceedings
of the 5th International Congress of the European Society for
Veterinary Virology: Veterinary virology in the new
millennium, Brescia, 27-30 August (E. Brocchi & A. Lavazza,
eds). Istituto Zooprofilattico Sperimentale della Lombardia e
dell’Emilia Romagna e Fondazione Iniziative Zooprofilattiche
e Zootecniche, Brescia, 173-174.
15. Lin F. & Kitching R.P. (2000). – Swine vesicular disease: an
overview. Vet. J., 160, 192-201.
16. Nardelli L., Lodetti E., Gualandi G.L., Burrow R.,
Goodridge D., Brown F. & Cartwright B. (1968). – A foot and
mouth disease syndrome in pigs caused by an enterovirus.
Nature, 219, 1275-1276.
17. World Organisation for Animal Health (OIE) (2004). – Swine
Vesicular Disease, Chapter 2.1.3. In Manual of Diagnostic
Tests and Vaccines for Terrestrial Animals, 5th Ed. OIE, Paris.
18. Zanardi G. (1999). – Malattia vescicolare del suino da
enterovirus: considerazioni epidemiologiche in seguito ai
focolai verificatisi in Lombardia nel 1998/99. PhD thesis,
University of Milan.
19. Zanardi G., Bellini S., Tranquillo V.M., Avisani D. &
Bonacina C. (2003). – Epidemiological features of swine
vesicular disease (SVD) outbreaks in the Lombardy region
(Italy) in 2002. In 10th Symposium of the International
Society for Veterinary Epidemiology and Economics (ISVEE),
17-21 November, Viña del Mar, Chile.
20. Zhang G., Haydon D.T., Knowles N.J. & McCauley J.W.
(1999). – Molecular evolution of swine vesicular disease
virus. J. gen. Virol., 80, 639-651.